Dosing and Safety Considerations Optimal dosing remains poorly defined, with significant variations in recommended doses across studies and antioxidant groups
Sukhovskaya IV, Borvinskaya EV, Smirnov LP
They are not approved for human or animal use
Results are not permanent they typically last 23 months after the final session, gradually fading if treatment stops
Other side effects can be kidney stones (typically when a patient has a history of them), a jittery feeling right after an infusion, or tiredness post infusion
It is well known that activity of cytosolic enzymes in blood plasma is increased as a result of exhaustive exercise CONCLUSION Performance gain 7-10 days after treatment #1 was significant (+2.1%) with total performance gains from intravenous glutathione +7.2% over 36 days (57:30 to 52:21 minutes:seconds), averaging a remarkable +1.8% per treatment administered